` 5 "

: Jakavi 5 Mg. ?  »
|
-

PER OS

Tablets

Jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis.

149 85 33747 00

Novartis Pharma Stein Ag, Switzerland

05/2013 - 04/2018

.
, .
.
/
Ruxolitinib as phosphate 5 MG
Blister pvc/pctfe 56 x TABLETS 24
Bottle hdpe 60 x TABLETS 24

*

*

 

.

? !
 »
 
" !
 
238
, ,